ANI Pharmaceuticals Inc (NASDAQ:ANIP) price on Friday, February 28, rose 13.39% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $61.89.
A look at the stock’s price movement, the close in the last trading session was $54.58. Turning to its 52-week performance, $70.81 and $52.50 were the 52-week high and 52-week low respectively. Overall, ANIP moved 4.28% over the past month.
ANI Pharmaceuticals Inc’s market cap currently stands at around $1.30 billion, with investors looking forward to this quarter’s earnings report slated for in April.
Analysts have a consensus estimate of 169.96M for the company’s revenue for the quarter, with a low and high estimate of 163.7M and 177.2M respectively. The average forecast suggests up to a 23.67% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 732.54M, representing a 19.23% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ANIP is a 50% Buy. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 2 recommend ANIP as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ANIP’s current price about 5.72% and 8.42% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 62.11, while 7-day volatility ratio is 4.40% and 3.23% in the 30-day chart. Further, ANI Pharmaceuticals Inc (ANIP) has a beta value of 0.65, and an average true range (ATR) of 2.20. Analysts have given the company’s stock an average 52-week price target of $71.5, forecast between a low of $60 and high of $83. Looking at the price targets, the low is 3.05% off current price level while to achieve the yearly target high, price needs to move -34.11%. Nonetheless, investors will most likely welcome a -15.53% jump to $71.5 which is the analysts’ median price.
If we refocus on ANI Pharmaceuticals Inc (NASDAQ:ANIP), historical trading data shows that trading volumes averaged 230.36K over the past 3 months. The company’s latest data on shares outstanding shows there are 21.07 million shares.
The 18.85% of ANI Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 93.77% of the company’s shares. Current price change has pushed the stock 11.96% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ANIP stock continues to rise going into the next quarter.
